118 related articles for article (PubMed ID: 18212328)
1. Re: Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma, author response.
Zahm SH; Morton LM; Bernstein L; Wang SS; Colt JS; Severson RK; Welch R; Hartge P
Carcinogenesis; 2008 May; 29(5):1084-5. PubMed ID: 18212328
[No Abstract] [Full Text] [Related]
2. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.
Morton LM; Bernstein L; Wang SS; Hein DW; Rothman N; Colt JS; Davis S; Cerhan JR; Severson RK; Welch R; Hartge P; Zahm SH
Carcinogenesis; 2007 Aug; 28(8):1759-64. PubMed ID: 17522066
[TBL] [Abstract][Full Text] [Related]
3. Reply: letter to the editor in response to Morton et al. (2007) Carcinogenesis, 28, 1759-1764.
Bailey JE; Skare JA
Carcinogenesis; 2008 Sep; 29(9):1851. PubMed ID: 18218828
[No Abstract] [Full Text] [Related]
4. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
Gibson TM; Smedby KE; Skibola CF; Hein DW; Slager SL; de Sanjosé S; Vajdic CM; Zhang Y; Chiu BC; Wang SS; Hjalgrim H; Nieters A; Bracci PM; Kricker A; Zheng T; Kolar C; Cerhan JR; Darabi H; Becker N; Conde L; Holford TR; Weisenburger DD; De Roos AJ; Butterbach K; Riby J; Cozen W; Benavente Y; Palmers C; Holly EA; Sampson JN; Rothman N; Armstrong BK; Morton LM
Cancer Causes Control; 2013 Jan; 24(1):125-34. PubMed ID: 23160945
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS
Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma.
Zhang Y; Hughes KJ; Zahm SH; Zhang Y; Holford TR; Dai L; Bai Y; Han X; Qin Q; Lan Q; Rothman N; Zhu Y; Leaderer B; Zheng T
Am J Epidemiol; 2009 Nov; 170(10):1222-30. PubMed ID: 19822571
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma.
Kilfoy BA; Zheng T; Lan Q; Han X; Holford T; Hein DW; Qin Q; Leaderer B; Morton LM; Yeager M; Boyle P; Zhao P; Chanock S; Rothman N; Zhang Y
Cancer Causes Control; 2010 Jan; 21(1):127-33. PubMed ID: 19809881
[TBL] [Abstract][Full Text] [Related]
8. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2.
Gago-Dominguez M; Bell DA; Watson MA; Yuan JM; Castelao JE; Hein DW; Chan KK; Coetzee GA; Ross RK; Yu MC
Carcinogenesis; 2003 Mar; 24(3):483-9. PubMed ID: 12663508
[TBL] [Abstract][Full Text] [Related]
9. N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus.
Cooper GS; Treadwell EL; Dooley MA; St Clair EW; Gilkeson GS; Taylor JA
J Rheumatol; 2004 Jan; 31(1):76-80. PubMed ID: 14705222
[TBL] [Abstract][Full Text] [Related]
10. N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.
Cocco P; Zucca M; Sanna S; Satta G; Nonne T; Angelucci E; Gabbas A; Rais M; Malpeli G; Campagna M; Scarpa A; G Ennas M
Hematol Oncol; 2016 Jun; 34(2):79-83. PubMed ID: 25689677
[TBL] [Abstract][Full Text] [Related]
11. Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye.
Nohynek GJ; Skare JA; Meuling WJ; Hein DW; De Bie AT; Toutain H
Food Chem Toxicol; 2004 Nov; 42(11):1885-91. PubMed ID: 15350687
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
13. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
Smelt VA; Mardon HJ; Sim E
Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
[TBL] [Abstract][Full Text] [Related]
14. Micronuclei assessment in the urothelial cells of women using hair dyes and its modulation by genetic polymorphisms.
Espinoza F; Silverman D; Kogevinas M; Creus A; Fernández F; García-Closas M; Tardon A; García-Closas R; Serra C; Carrato A; Rothman N; Dosemeci M; Malats N; Marcos R
Cancer Lett; 2008 May; 263(2):259-66. PubMed ID: 18262724
[TBL] [Abstract][Full Text] [Related]
15. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
Walraven JM; Doll MA; Hein DW
J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
[TBL] [Abstract][Full Text] [Related]
17. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
18. Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of two novel allelic variants.
Payton MA; Sim E
Biochem Pharmacol; 1998 Feb; 55(3):361-6. PubMed ID: 9484803
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.
Hernández-González O; Ortiz-Zamudio JJ; Rodríguez-Pinal CJ; Alvarado-Morales I; Martínez-Jiménez VDC; Salazar-González RA; Correa-González LC; Gómez R; Portales-Pérez DP; Milán-Segovia RDC
Leuk Lymphoma; 2018 Aug; 59(8):1968-1975. PubMed ID: 29214875
[TBL] [Abstract][Full Text] [Related]
20. Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients.
Risch A; Smelt V; Lane D; Stanley L; van der Slot W; Ward A; Sim E
Pharmacol Toxicol; 1996 Apr; 78(4):235-40. PubMed ID: 8861781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
